Hotgen’s Pioneering Diagnostic Solutions Stands Out at Pharmed Vietnam 2024

Beijing Hotgen Biotech Co., Ltd. (Hotgen) successfully participated in the 2024 Pharmed & Healthcare Vietnam Exhibition during September 11-14th, 2024. This is the debut of Hotgen’s products in Vietnam exhibition.

During this event at the Saigon Exhibition and Convention Center (SECC) in Ho Chi Minh City, Hotgen presented its highly regarded mono-test chemiluminescence (CLIA) and Up-Converting Phosphor Technology (UPT) immunoassay solutions, along with its breakthrough small-molecule diagnostic technology and a range of colloidal gold rapid test products. These innovative diagnostic products attracted numerous attendees and received high praise from industry experts. During the exhibition, we engaged in in-depth discussions with local professionals, exploring the potentials of innovative in-vitro diagnostic (IVD) technologies in enhancing diagnostic capabilities in Vietnam and across the South-East Asian region.

Pharmed & Healthcare Vietnam 2024 provides a valuable opportunity for Hotgen to connect with the diagnostic industry in the region. We look forward to furthering collaborations with partners to advance healthcare solutions, for a healthier Vietnam, for a healthier world.